Leerink Swann Starts Calithera Biosciences (CALA) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Citi Starts Calithera Biosciences (CALA) at Buy
October 27, 2014 8:45 AM EDTCiti initiated coverage on Calithera Biosciences (NASDAQ: CALA) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... MoreWells Fargo Starts Calithera Biosciences (CALA) at Outperform
October 27, 2014 7:09 AM EDTWells Fargo initiated coverage on Calithera Biosciences (NASDAQ: CALA) with an Outperform rating and a price target of $19-$20.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... More